The Patent Finder

Terms ending in 2035

Amyris, Inc.

Every in-force patent on Amyris, Inc.'s record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 10,041,092Methods for Genomic Integration
In force
 · High confidence
Amyris, Inc.In forceHigh confidence
US 11,390,888Methods for Genomic Integration
In force
 · High confidence
Amyris, Inc.In forceHigh confidence
US 9,476,065Methods for Genomic Integration
In force
 · High confidence
Amyris, Inc.In forceHigh confidence
US 12,473,556Methods for Stabilizing Production of Acetyl-Coenzyme a Derived Compounds
In force
 · High confidence
Total Marketing ServicesIn forceHigh confidence
US 10,071,034Solvent Compositions
In force
 · High confidence
Amyris, Inc.In forceHigh confidence
US 10,695,273Compositions Containing Bio-Based Farnesene or Compounds Derived Therefrom and Their Use in Consumer and Industrial Products
In force
 · High confidence
Amyris, Inc.In forceHigh confidence
6 of 6 patents shown. Soonest term end first, then patent number.
5 of these are in force and held by Amyris, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited